XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues    
Total revenues $ 10,539,299 $ 4,813,744
Operating expenses    
Cost of sales and supportive services 4,720,116 250,848
Selling, general and administrative 3,518,030 4,056,184
Research and development 3,546,776 2,302,785
Patent expenses 193,258 193,334
Total operating expenses 11,978,180 6,803,151
Operating loss (1,438,881) (1,989,407)
Gain from change in fair value of warrant liability 351,104 918,801
Other income, net 23,322 25,568
Loss before income taxes (1,064,455) (1,045,038)
Benefit for income taxes 703,406 232,933
Net and comprehensive loss $ (361,049) $ (812,105)
Basic loss per share (in dollars per share) $ (0.00) $ (0.01)
Diluted loss per share (in dollars per share) $ (0.01) $ (0.02)
Weighted average shares outstanding: basic (in shares) 73,070,565 76,757,010
Weighted average shares outstanding: diluted (in shares) 73,883,058 77,572,587
Product Sales and Supportive Services [Member]    
Revenues    
Total revenues $ 7,320,872 $ 3,523,343
Research and Development [Member]    
Revenues    
Total revenues $ 3,218,427 $ 1,290,401